Shefali Mody

414 total citations
16 papers, 320 citations indexed

About

Shefali Mody is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Epidemiology. According to data from OpenAlex, Shefali Mody has authored 16 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 3 papers in Pharmacology and 3 papers in Epidemiology. Recurrent topics in Shefali Mody's work include Atrial Fibrillation Management and Outcomes (4 papers), Pneumonia and Respiratory Infections (3 papers) and Emergency and Acute Care Studies (3 papers). Shefali Mody is often cited by papers focused on Atrial Fibrillation Management and Outcomes (4 papers), Pneumonia and Respiratory Infections (3 papers) and Emergency and Acute Care Studies (3 papers). Shefali Mody collaborates with scholars based in United States, India and Jordan. Shefali Mody's co-authors include Bartolomé R. Celli, Claudia Côté, Marya D. Zilberberg, L. J. Dordelly, Jeff Schein, Richard W. Grant, Carmela Benson, William H. Olson, Monika Raut and Alan C. Fisher and has published in prestigious journals such as Blood, European Respiratory Journal and Osteoarthritis and Cartilage.

In The Last Decade

Shefali Mody

13 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shefali Mody United States 5 174 82 65 48 40 16 320
Gili Lushkov Israel 9 78 0.4× 50 0.6× 33 0.5× 24 0.5× 23 0.6× 13 273
Giuseppe Paglino Italy 6 268 1.5× 47 0.6× 15 0.2× 122 2.5× 23 0.6× 8 420
J. Frenkiel France 7 56 0.3× 40 0.5× 27 0.4× 8 0.2× 41 1.0× 15 234
Harish Jarrett United States 7 275 1.6× 110 1.3× 48 0.7× 73 1.5× 3 0.1× 12 378
Nisha Rathi United States 9 62 0.4× 62 0.8× 25 0.4× 11 0.2× 34 0.8× 20 205
Tünay Kuru United States 7 172 1.0× 75 0.9× 10 0.2× 18 0.4× 11 0.3× 10 318
Emilia Sawicka Poland 10 169 1.0× 62 0.8× 22 0.3× 43 0.9× 7 0.2× 26 363
Valerie Hopkins United Kingdom 5 82 0.5× 27 0.3× 70 1.1× 17 0.4× 134 3.4× 6 386
Tom White United States 7 44 0.3× 41 0.5× 51 0.8× 91 1.9× 39 1.0× 11 347
Elizabeth Van Cott United States 10 69 0.4× 21 0.3× 33 0.5× 43 0.9× 125 3.1× 16 319

Countries citing papers authored by Shefali Mody

Since Specialization
Citations

This map shows the geographic impact of Shefali Mody's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shefali Mody with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shefali Mody more than expected).

Fields of papers citing papers by Shefali Mody

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shefali Mody. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shefali Mody. The network helps show where Shefali Mody may publish in the future.

Co-authorship network of co-authors of Shefali Mody

This figure shows the co-authorship network connecting the top 25 collaborators of Shefali Mody. A scholar is included among the top collaborators of Shefali Mody based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shefali Mody. Shefali Mody is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
3.
4.
Mody, Shefali, et al.. (2023). Developments in application of optogenetics in pain and anxiety: a literature review. InterConf. 209–225. 2 indexed citations
5.
Mody, Shefali, et al.. (2023). Heart failure in patients with metabolic syndrome X. PubMed. 11(1). e162–e162. 3 indexed citations
6.
Mody, Shefali, et al.. (2023). Lung Donor Selection and Management: An Updated Review. 7(4). 1–54.
7.
Bookhart, Brahim, et al.. (2013). Treatment of Pulmonary Embolism Treatment With Rivaroxaban and LMWH-VKA: Length of Stay and Economic Implications in the Emergency Department Setting. Annals of Emergency Medicine. 62(4). S9–S9. 1 indexed citations
8.
LaMori, Joyce, H.J. Gross, Ashaben Patel, et al.. (2011). PCV13 BURDEN OF COMORBIDITIES AMONG PATIENTS WITH ATRIAL FIBRILLATION. Value in Health. 14(3). A34–A34. 2 indexed citations
9.
LaMori, Joyce, H.J. Gross, Aarti Patel, et al.. (2011). PCV14 DYSPEPSIA AND DISEASE BURDEN AMONG PATIENTS WITH ATRIAL FIBRILLATION (AF). Value in Health. 14(3). A34–A34. 1 indexed citations
10.
Kozma, Chris M, Michael Dickson, Monika Raut, et al.. (2010). Economic benefit of a 1-day reduction in hospital stay for community-acquired pneumonia (CAP). Journal of Medical Economics. 13(4). 719–727. 29 indexed citations
11.
Schein, Jeff, et al.. (2009). Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US. Current Medical Research and Opinion. 25(9). 2151–2157. 56 indexed citations
12.
Frei, Christopher R., Eric M. Mortensen, Marcos I. Restrepo, et al.. (2009). Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: A US-based study. Current Medical Research and Opinion. 25(4). 859–868. 12 indexed citations
13.
Mody, Shefali, Meenakshi Jolly, Mary Kwasny, & Joel A. Block. (2008). Patient reported outcomes and analgesia use in osteoarthritis of the knee. Osteoarthritis and Cartilage. 16(11). 1294–1299. 7 indexed citations
14.
Côté, Claudia, Marya D. Zilberberg, Shefali Mody, L. J. Dordelly, & Bartolomé R. Celli. (2007). Haemoglobin level and its clinical impact in a cohort of patients with COPD. European Respiratory Journal. 29(5). 923–929. 202 indexed citations
15.
Mody, Shefali, et al.. (2006). PUK5 EPOETIN ALFA AND DARBEPOETIN ALFA DOSING PATTERNS IN ANEMIC PRE-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS. Value in Health. 9(3). A96–A96. 2 indexed citations
16.
McLaughlin, Trent, Shefali Mody, & R. Scott McKenzie. (2006). PCN25 REAL WORLD DOSING OF ERYTHROPOIETIC AGENTS IN A NATIONWIDE SAMPLE OF PATIENTS WITH CANCER RECEIVING CHEMOTHERAPY: RESULTS FROM A LARGE RETROSPECTIVE OBSERVATIONAL STUDY. Value in Health. 9(3). A111–A111. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gili Lushkov Breakdown of academic impact, for papers by Giuseppe Paglino Breakdown of academic impact, for papers by J. Frenkiel Breakdown of academic impact, for papers by Harish Jarrett Breakdown of academic impact, for papers by Nisha Rathi Breakdown of academic impact, for papers by Tünay Kuru Breakdown of academic impact, for papers by Emilia Sawicka Breakdown of academic impact, for papers by Valerie Hopkins Breakdown of academic impact, for papers by Tom White Breakdown of academic impact, for papers by Elizabeth Van Cott
Rankless by CCL
2026